Bioventus Inc - Ordinary Shares - Class A
BVS - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$775.07M
Close$
$24.58
115.2% upside
Current Fair Value
115.2% upsideUndervalued by 115.2% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $775.07 Million |
|---|---|
| Enterprise Value | $1.01 Billion |
| Earnings per Share | $0.34 |
| Beta | 0.64 |
| Outstanding Shares | 67,869,148 |
Return
| Return on Equity | 23.86% |
|---|---|
| Return on Assets | 8.09% |
| Return on Invested Capital | 12.46% |
Valuation & Multiples
| P/E Ratio | 16.59 |
|---|---|
| PEG | 4.76 |
| Price to Sales | 1.43 |
| Price to Book Ratio | 2.86 |
| Enterprise Value to Revenue | 1.73 |
| Enterprise Value to EBIT | 15.55 |
| Enterprise Value to Net Income | 18 |
| Total Debt to Enterprise | 0.26 |
| Debt to Equity | 1.16 |
Revenue Sources
No data
Last Earnings Call
Report Date
November 3, 2026
EPS Estimate
$0.15
Consensus analyst estimateRevenue Estimate
$149.51 M
Consensus analyst estimateNext Earnings Call
Expected Date
March 4, 2027
EPS Estimate
$0.25
Consensus analyst estimateRevenue Estimate
$169.96 M
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.0000▼ 24.64% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.73%▼ 79.19% |
|---|---|
| Total Invested | $6.79M▼ 98.68% |
| Investors Holding | 32▼ 129.00% |
About Bioventus Inc
700 employees
Bioventus delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. The Innovations For Active Healing from Bioven...